FDA Inspection 1328042 — The University Of Texas MD Anderson Cancer Center, Department Of Radiation Physics, Division Of Radiation Oncology

The University Of Texas MD Anderson Cancer Center, Department Of Radiation Physics, Division Of Radiation Oncology — FEI 3030564015

The FDA completed an inspection of The University Of Texas MD Anderson Cancer Center, Department Of Radiation Physics, Division Of Radiation Oncology on Jul 27, 2026 in Houston, TX. The inspection was classified VAI (Voluntary Action Indicated — objectionable conditions or practices were found, but the agency is not prepared to take or recommend any administrative or regulatory action). 9 citations were issued during this inspection. Product area: Devices.

Inspection Details

Classification
Voluntary Action Indicated (VAI)
End Date
Jul 27, 2026
Fiscal Year
2026
Product Type
Devices
Project Area
Compliance: Devices
Location
Houston, TX (United States)

Citations

IDCFRDescription
23061ISO 13485:2016 Clause 5.6.1QMS not reviewed by top management at documented planned intervals
23117ISO 13485:2016 Clause 7.3.6Inadequate design and development verification for interfaced device
23119ISO 13485:2016 Clause 7.3.7Design and development validation not performed as planned
23133ISO 13485:2016 Clause 7.3.9Requirements for design and development changes not met before implementation
23150ISO 13485:2016 Clause 7.4.3Purchased product verification activities not established or implemented
23171ISO 13485:2016 Clause 7.5.6Procedures for production/service provision software validation not documented
23217ISO 13485:2016 Clause 8.2.2Correction or corrective action resulting from complaint handling not documented
23220ISO 13485:2016 Clause 8.2.4Internal audits not conducted to ensure QMS meets requirements and is effective
23258ISO 13485:2016 Clause 8.5.2Corrective action procedures not documented

Sources: openFDA, FDA Data Dashboard, FDA.gov. Report a data issue: hello@regdatalab.com.